Skip to main content
. 1999 Jun;127(4):813–825. doi: 10.1038/sj.bjp.0702606

Figure 5.

Figure 5

Incorporation of ET-18-OCH3 in human resting and mitogen-activated T-lymphocytes. Human resting T-lymphocytes (solid circles) and T-cells activated for 4 days with 0.5 μg ml PHA and for 1 additional day with 0.5 μg ml−1 PHA and 50 U ml−1 IL-2 (solid squares) were incubated with 5 μg ml−1 ET-18-OCH3 and 0.05 μCi ml−1 of [3H]-ET-18-OCH3 for the times indicated to measure incorporation of the ether lipid into the cell as described in the Methods section. Data are shown as mean values±s.e.mean. from three independent experiments.

HHS Vulnerability Disclosure